Leading companies at the forefront of the fight against complicated urinary tract infections (cUTIs) are pioneering innovative treatments, including Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Meiji Seika Pharma, Fedora Pharmaceuticals, and Evopoint Pharmaceuticals. These companies are shaping the future of cUTI management with a focus on new...